{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T05:29:44Z","timestamp":1731562184364,"version":"3.28.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.transci.2024.103909","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T05:19:03Z","timestamp":1709875143000},"page":"103909","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and risk factors of hepatic sinusoidal obstruction syndrome in children after hematopoietic stem cell transplantation: A single-center experience"],"prefix":"10.1016","volume":"63","author":[{"given":"\u0130brahim","family":"Kartal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Da\u011fdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O\u011fuz Salih","family":"Din\u00e7er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fclya Kangal","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcnsal","family":"\u00d6zgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davut","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.transci.2024.103909_bib1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00432-021-03732-1","article-title":"Analysis of risk factors for hepatic sinusoidal obstruction syndrome following allogeneic hematopoietic stem cell transplantation in pediatric patients","volume":"148","author":"Kloehn","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.transci.2024.103909_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"10.1016\/j.transci.2024.103909_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"10.1016\/j.transci.2024.103909_bib4","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.bbmt.2018.06.013","article-title":"Risk score for the development of veno-occlusive disease after allogeneic hematopoietic cell transplant","volume":"24","author":"Strouse","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2024.103909_bib5","unstructured":"Corbacioglu S., Newburger P. Hepatic sinusoidal obstruction syndrome (veno-occlusive disease) in children."},{"key":"10.1016\/j.transci.2024.103909_bib6","unstructured":"Zimmerman H.J. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver; 1999."},{"issue":"3","key":"10.1016\/j.transci.2024.103909_bib7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment","volume":"22","author":"Dalle","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2024.103909_bib8","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1542\/peds.2005-1789","article-title":"Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients","volume":"117","author":"Ouach\u00e9e-Chardin","year":"2006","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.transci.2024.103909_bib9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","article-title":"Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation","volume":"40","author":"Cheuk","year":"2007","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"10.1016\/j.transci.2024.103909_bib10","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.transci.2024.103909_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbmt.2018.09.027","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease after autologous or allogeneic hematopoietic stem cell transplantation in children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"10.1016\/j.transci.2024.103909_bib12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12185-014-1578-y","article-title":"Experience from a single paediatric transplant centre with identification of some protective and risk factors concerning the development of hepatic veno-occlusive disease in children after allogeneic hematopoietic stem cell transplant","volume":"99","author":"Maximova","year":"2014","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.transci.2024.103909_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1700895","article-title":"Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution","volume":"20","author":"Kami","year":"1997","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"10.1016\/j.transci.2024.103909_bib14","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.bjc.6603097","article-title":"High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy","volume":"94","author":"de Jonge","year":"2006","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.transci.2024.103909_bib15","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"10.1016\/j.transci.2024.103909_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cts.12709","article-title":"Reduced risk of sinusoidal obstruction syndrome of the liver after busulfan-cyclophosphamide conditioning prior to allogeneic hematopoietic stem cell transplantation","volume":"13","author":"El-Serafi","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"5","key":"10.1016\/j.transci.2024.103909_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1084-2756(03)00066-6","article-title":"Hepatic function and physiology in the newborn","volume":"8","author":"Beath","year":"2003","journal-title":"Semin Neonatol"},{"issue":"4","key":"10.1016\/j.transci.2024.103909_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.transci.2024.103909_bib19","first-page":"63","article-title":"Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation","volume":"17","author":"McKay","year":"1996","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2024.103909_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2005-923315","article-title":"Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis","volume":"25","author":"Ramm","year":"2005","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.transci.2024.103909_bib21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2009-03-212282","article-title":"Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation","volume":"114","author":"Maradei","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2024.103909_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"10.1016\/j.transci.2024.103909_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bmt.1701321","article-title":"Parenteral glutamine protects hepatic function during bone marrow transplantation","volume":"22","author":"Brown","year":"1998","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"10.1016\/j.transci.2024.103909_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1399-3046.2009.01285.x","article-title":"Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution","volume":"14","author":"Lakshminarayanan","year":"2010","journal-title":"Pedia Transpl"},{"issue":"4","key":"10.1016\/j.transci.2024.103909_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1399-0012.2012.01604.x","article-title":"Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review","volume":"26","author":"Zhang","year":"2012","journal-title":"Clin Transpl"},{"issue":"10","key":"10.1016\/j.transci.2024.103909_bib26","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.bbmt.2016.07.001","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the international compassionate-use program","volume":"22","author":"Corbacioglu","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"10.1016\/j.transci.2024.103909_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27269","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: final results from a post hoc analysis of data from an expanded-access program","volume":"65","author":"Kernan","year":"2018","journal-title":"Pedia Blood Cancer"},{"issue":"3","key":"10.1016\/j.transci.2024.103909_bib28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.transci.2024.103909_bib29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/hpb.12047","article-title":"Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab","volume":"15","author":"Hubert","year":"2013","journal-title":"HPB (Oxf)"},{"issue":"5","key":"10.1016\/j.transci.2024.103909_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41409-017-0066-4","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease after high-dose intravenous busulfan\/melphalan conditioning therapy in high-risk Ewing Sarcoma","volume":"53","author":"Abate","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.transci.2024.103909_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","article-title":"Platelet transfusion refractoriness","volume":"142","author":"Hod","year":"2008","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.transci.2024.103909_bib32","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00277-019-03698-8","article-title":"Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation","volume":"98","author":"Cai","year":"2019","journal-title":"Ann Hematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:24:56Z","timestamp":1731543896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1473050224000685"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103909","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and risk factors of hepatic sinusoidal obstruction syndrome in children after hematopoietic stem cell transplantation: A single-center experience","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103909"}}